<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: immunosuppressive drugs</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Researchers develop implantable, bioengineered rat kidney (w/ video)</title>
   	 <description>Bioengineered rat kidneys developed by Massachusetts General Hospital (MGH) investigators successfully produced urine both in a laboratory apparatus and after being transplanted into living animals. In their report, receiving advance online publication in Nature Medicine, the research team describes building functional replacement kidneys on the structure of donor organs from which living cells had been stripped, an approach previously used to create bioartificial hearts, lungs and livers.</description>
     <link>http://medicalxpress.com/news/2013-04-implantable-bioengineered-rat-kidney-video.html</link>
	 <category>Medical research</category>
	 <pubDate>Sun, 14 Apr 2013 13:00:17 EST</pubDate>
	 <guid isPermaLink="false">news285140804</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/massgeneralt.jpg" width="90" height="90" />
</item>
<item>
     <title>Worlds first womb transplant woman is pregnant</title>
   	 <description>The first woman ever to receive a uterus from a deceased donor, is two-weeks pregnant following a successful embryo transplant, her doctors said on Friday.</description>
     <link>http://medicalxpress.com/news/2013-04-worlds-womb-transplant-woman-pregnant.html</link>
	 <category>Obstetrics &amp; gynaecology</category>
	 <pubDate>Fri, 12 Apr 2013 08:39:28 EST</pubDate>
	 <guid isPermaLink="false">news284974758</guid>
	 
</item>
<item>
     <title>A better bone marrow transplant: Preventing graft-versus-host disease</title>
   	 <description>Bone marrow transplant is a key treatment for patients with leukemia, lymphoma, multiple myeloma and other blood disorders.</description>
     <link>http://medicalxpress.com/news/2013-03-bone-marrow-transplant-graft-versus-host-disease.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 01 Mar 2013 12:35:38 EST</pubDate>
	 <guid isPermaLink="false">news281363715</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/abetterbonem.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists find key element of lupus, suggesting better drug targets</title>
   	 <description>A team led by scientists at The Scripps Research Institute (TSRI) has identified specific cellular events that appear key to lupus, a debilitating autoimmune disease that afflicts tens of millions of people worldwide. The findings suggest that blocking this pathway in lupus-triggering cells could be a potent weapon against the disease.</description>
     <link>http://medicalxpress.com/news/2013-02-scientists-key-element-lupus-drug.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 04 Feb 2013 17:43:05 EST</pubDate>
	 <guid isPermaLink="false">news279222177</guid>
	 
</item>
<item>
     <title>Research: Lupus drugs carry no significant cancer risk for patients</title>
   	 <description>People who take immunosuppressive drugs to treat lupus do not necessarily increase their cancer risk according to new research led by scientists at the Research Institute of the McGill University Health Centre (RI-MUHC). This landmark study, which was published in Annals of the Rheumatic Diseases this month, addresses long-standing fears of a link between lupus medication and cancer.</description>
     <link>http://medicalxpress.com/news/2013-01-lupus-drugs-significant-cancer-patients.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 24 Jan 2013 12:58:39 EST</pubDate>
	 <guid isPermaLink="false">news278254710</guid>
	 
</item>
<item>
     <title>Researchers reveal most effective treatment for common kidney disorder</title>
   	 <description>The results of a pioneering UK-wide clinical trial that compared treatments for patients with a common type of kidney disease has found one to be significantly more effective. The results of the study, published online in The Lancet today, will be recommended to clinicians worldwide as the most effective approach to treating the condition.</description>
     <link>http://medicalxpress.com/news/2013-01-reveal-effective-treatment-common-kidney.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 09 Jan 2013 09:44:22 EST</pubDate>
	 <guid isPermaLink="false">news276947047</guid>
	 
</item>
<item>
     <title>Are you ready for flu season?</title>
   	 <description>Each year the flu puts more than 200,000 Americans in the hospital and causes anywhere from 3,000 to 49,000 deaths. With the exception of the H1N1 flu (also called swine flu) in 2009, most of these deaths occur in people over 65. But even for healthy younger people, the flu—characterized by high fever, body aches, headaches, and coughing—can be rough.</description>
     <link>http://medicalxpress.com/news/2012-11-ready-flu-season.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 27 Nov 2012 08:03:37 EST</pubDate>
	 <guid isPermaLink="false">news273225802</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/areyoureadyf.jpg" width="90" height="90" />
</item>
<item>
     <title>Single gene variant in donors may affect survival of transplanted kidneys</title>
   	 <description>A single genetic variant in kidney donors' cells may help determine whether their transplanted organs will survive long term, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings provide new information that might be used to improve transplant longevity by revealing that the genetic make-up of kidney transplant donors affects the survival of transplanted organs.</description>
     <link>http://medicalxpress.com/news/2012-10-gene-variant-donors-affect-survival.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 11 Oct 2012 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news269192994</guid>
	 
</item>
<item>
     <title>Immune drug helps patients with serious kidney disorder</title>
   	 <description>A drug commonly used to treat immune disorders such as lymphoma and arthritis also benefits patients with an immune disorder of the kidneys that can lead to kidney failure, according to a study appearing in an upcoming issue of new study in the Journal of the American Society of Nephrology (JASN). The findings could help people who are living with the condition, called idiopathic membranous nephropathy (IMN), avoid taking the potentially toxic medications that are currently prescribed to treat it.</description>
     <link>http://medicalxpress.com/news/2012-07-immune-drug-patients-kidney-disorder.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 19 Jul 2012 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news261932296</guid>
	 
</item>
<item>
     <title>Successful transplantation of tissue-engineered vein in a child offers hope</title>
   	 <description>The first biologically tissue-engineered vein grown from a patient's own stem cells has been successfully transplanted into a 10-year-old girl with portal vein obstruction, dramatically enhancing her quality of life. These pioneering results, published online first in the Lancet, could offer a potential new way for patients lacking healthy veins to undergo dialysis or heart bypass surgery without the problems of synthetic grafts (that are prone to clots and blockages) or the need for lifelong immunosuppressive drugs.</description>
     <link>http://medicalxpress.com/news/2012-06-successful-transplantation-tissue-engineered-vein-child.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 13 Jun 2012 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news258811550</guid>
	 
</item>
<item>
     <title>Conditioning regimen beneficial for kidney recipients</title>
   	 <description>(HealthDay) -- Following a conditioning regimen of lymphoid irradiation (TLI) and antithymocyte globulin (ATG), the majority of HLA-matched kidney and hematopoietic cell transplant recipients can be withdrawn from immunosuppressive drugs, according to a small study published online March 8 in the American Journal of Transplantation.</description>
     <link>http://medicalxpress.com/news/2012-03-conditioning-regimen-beneficial-kidney-recipients.html</link>
	 <category>Surgery</category>
	 <pubDate>Wed, 28 Mar 2012 18:08:10 EST</pubDate>
	 <guid isPermaLink="false">news252176882</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/conditioning.jpg" width="90" height="90" />
</item>
<item>
     <title>Engineering whole organs: Closing in on a potential solution to the organ donor shortage?</title>
   	 <description>A new technique involving the use of an artificial scaffold into which a patient's own stem cells are inserted, turning it into a fully functional organ, could offer a potential solution to the donor shortage crisis, according to the second paper in this week's Lancet Series on stem cells. This pioneering approach to regenerating and transplanting organs requires no human donors, has no problems with rejection, and has no need for immunosuppressive drugs.</description>
     <link>http://medicalxpress.com/news/2012-03-potential-solution-donor-shortage.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 08 Mar 2012 18:30:04 EST</pubDate>
	 <guid isPermaLink="false">news250445974</guid>
	 
</item>
<item>
     <title>New transplant method may allow kidney recipients to live life free of anti-rejection medication</title>
   	 <description>New ongoing research published today in the journal Science Translational Medicine suggests organ transplant recipients may not require anti-rejection medication in the future thanks to the power of stem cells, which may prove to be able to be manipulated in mismatched kidney donor and recipient pairs to allow for successful transplantation without immunosuppressive drugs. Northwestern Medicine&amp;#174; and University of Louisville researchers are partnering on a clinical trial to study the use of donor stem cell infusions that have been specially engineered to &quot;trick&quot; the recipients' immune system into thinking the donated organ is part of the patient's natural self, thus gradually eliminating or reducing the need for anti-rejection medication.</description>
     <link>http://medicalxpress.com/news/2012-03-transplant-method-kidney-recipients-life.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 07 Mar 2012 14:00:02 EST</pubDate>
	 <guid isPermaLink="false">news250347854</guid>
	 
</item>
<item>
     <title>Cochlear implants may be safe, effective for organ transplant patients</title>
   	 <description>Cochlear implants may be a safe, effective option for some organ transplant patients who've lost their hearing as an unfortunate consequence of their transplant-related drug regime, researchers report.</description>
     <link>http://medicalxpress.com/news/2012-02-cochlear-implants-safe-effective-transplant.html</link>
	 <category>Other</category>
	 <pubDate>Fri, 10 Feb 2012 12:57:52 EST</pubDate>
	 <guid isPermaLink="false">news248101048</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/cochlearimpl.jpg" width="90" height="84" />
</item>
<item>
     <title>Stop taking steroids: Kidney transplant recipients may not need long-term prednisone</title>
   	 <description>Rapid discontinuation of the immunosuppressive steroid prednisone after a kidney transplant can help prevent serious side effects, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Also, doing so does not appear to jeopardize the long-term survival of transplant patients and their new organs.</description>
     <link>http://medicalxpress.com/news/2012-01-steroids-kidney-transplant-recipients-long-term.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 26 Jan 2012 17:00:05 EST</pubDate>
	 <guid isPermaLink="false">news246806737</guid>
	 
</item>
<item>
     <title>Weaning transplant recipients from their immunosuppressive drugs</title>
   	 <description>Transplant surgeons live in the hope that one day they will be able to wean at least some of their patients off the immunosuppressive drugs that must be taken to prevent rejection of a transplanted organ. A team of researchers led by Alberto S&amp;#225;nchez-Fueyo, at the University of Barcelona, Spain, has now identified markers that might make this possible for liver transplant recipients.</description>
     <link>http://medicalxpress.com/news/2011-12-weaning-transplant-recipients-immunosuppressive-drugs.html</link>
	 <category>Other</category>
	 <pubDate>Mon, 12 Dec 2011 12:00:02 EST</pubDate>
	 <guid isPermaLink="false">news242905934</guid>
	 
</item>
<item>
     <title>Time to stop giving toxic drugs to kidney transplant patients?</title>
   	 <description>Patients who receive kidney transplants must take lifelong medications that, while preventing organ rejection, can also compromise other aspects of health. Immunosuppresive drugs called calcineurin inhibitors protect transplanted organs from being rejected, but they can be toxic to the kidneys over the long term and can make patients susceptible to infection, cancer, and other threats.</description>
     <link>http://medicalxpress.com/news/2011-09-toxic-drugs-kidney-transplant-patients.html</link>
	 <category>Other</category>
	 <pubDate>Thu, 22 Sep 2011 18:32:54 EST</pubDate>
	 <guid isPermaLink="false">news235935148</guid>
	 
</item>
<item>
     <title>Substitution of brand name with generic drug proves safe for transplant recipients</title>
   	 <description>A new study published in the American Journal of Transplantation reveals that substitution of a brand name immunosuppressive drug with a generic (manufactured by Sandoz) for preventing rejection of transplanted organs appears to be safe for transplant recipients.</description>
     <link>http://medicalxpress.com/news/2011-09-substitution-brand-drug-safe-transplant.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 13 Sep 2011 11:28:01 EST</pubDate>
	 <guid isPermaLink="false">news235132066</guid>
	 
</item>
<item>
     <title>Sweden hospital in lab-made windpipe transplant</title>
   	 <description>A 36-year-old man who had tracheal cancer has received a new lab-made windpipe seeded with his own stem cells in a procedure in Sweden they call the first successful attempt of its kind, officials said Thursday.</description>
     <link>http://medicalxpress.com/news/2011-07-landmark-transplant-stemcell-coated-artificial-windpipe.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 07 Jul 2011 15:10:36 EST</pubDate>
	 <guid isPermaLink="false">news229270132</guid>
	 
</item>
<item>
     <title>Stem cell technology used in unique surgery</title>
   	 <description>Surgeon and Professor Michael Olausson was able to create a new connection with the aid of this blood vessel between the liver and the intestines, necessary to cure the girl. The girl is now in good health, and her prognosis is very good. The girl developed during her first year of life a blood clot in the blood vessel that leads blood from the intestines to the liver. This introduced the risk that she would experience life-threatening internal bleeding. The condition can be cured if it is possible to direct the blood along the correct path, back into the liver. In optimal cases, the surgery can be performed using blood vessels from other parts of the patient's body, but a liver transplant may be necessary if the surgery is unsuccessful due to a lack of sufficient blood vessels. A liver transplant will involve subsequent lifelong treatment with immunosuppressive drugs.</description>
     <link>http://medicalxpress.com/news/2011-05-stem-cell-technology-unique-surgery.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 09 May 2011 11:38:56 EST</pubDate>
	 <guid isPermaLink="false">news224159917</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/stemcelltech.jpg" width="90" height="90" />
</item>


</channel>
</rss>
